Cerus Corp (CERS) bonds
CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3023% below fair value
$1.99+0.05 (+2.32%)
Close on Nov 13, 2026Market cap $400.03MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Cerus reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2018
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Cerus's 10-Q for the period ended Jun 30, 2026
| Issue | Carrying value |
|---|---|
| Revolving Loan | $30.09M |
| Term Loan | $35.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn | Expires |
|---|---|---|---|
| Prior Revolving Loan Credit Agreement | $20.00M | – | Mar 1, 2028 |
| Revolving Loan Credit Agreement | $30.00M | – | Mar 1, 2028 |
| Prior Term Loan Credit Agreement | $5.00M | – | – |
| Term Loan Credit Agreement | $65.00M | $35.00M | – |
See a number that looks wrong?